Dr. Thomas Creighton Mitchell, MD

Dr. Mitchell practices at Asheville Endocrinology Consultants, PA in Asheville, North Carolina.

Dr. Mitchell's NPI, 1376751909, was assigned on May 18, 2007. Dr. Mitchell graduated from University of Tennessee, Hsc, College of Medicine in 2006. Dr. Mitchell holds North Carolina license 2014-00812.

Dr. Mitchell's primary practice is Asheville Endocrinology Consultants, PA, at 750 Alliance Ct, Asheville, NC 28806 in Buncombe County. The practice phone is (828) 670-6812.

Dr. Mitchell's primary practice is Asheville Endocrinology Consultants, PA in Asheville, North Carolina. Dr. Mitchell is also affiliated with Mission Hospital. The medical group on file is Novant Health Plastic & Reconstructive Surgery - South Asheville. Dmand AI also links Dr. Mitchell to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mitchell practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mitchell's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Mitchell is licensed in North Carolina.

CMS data shows 5,685 Medicare services from Dr. Mitchell across 30 procedure codes in 2024, for 478 Medicare patients. Medicare paid $158,588 for them. Every service was in an office.

CMS counts 478 Medicare patients who saw Dr. Mitchell in 2024. The largest group is 65 to 74, with 238 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mitchell's median patient age at 71, with 59% women.

In 2024, Dr. Mitchell wrote 6,162 Medicare Part D claims for 775 patients. 35% of them were for generic drugs. CMS names the drug for 5,801 of them, across 74 drugs with 11 or more claims each, at $3,216,405 in total drug cost. In 2023, CMS named 5,922 claims across 77 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Mitchell for performance year 2024, reported as part of a group. Dr. Mitchell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mitchell as offering telehealth.

CMS Open Payments shows 194 general payments to Dr. Mitchell from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 57% of the total. Tandem Diabetes Care, Inc. paid the most, $4,591.

Dr. Mitchell graduated from University of Tennessee, Hsc, College of Medicine in 2006.